Novo Nordisk

novonordisk.com · Denmark

Novo Nordisk is a global healthcare company that researches, develops, manufactures, and markets pharmaceutical products, with a primary focus on diabetes care, obesity treatments, and other serious chronic diseases such as rare blood and endocrine disorders. It sells prescription medicines and related therapies to healthcare systems, hospitals, and pharmacies worldwide through a mix of direct sales and distribution partners. The company generates revenue from patented drugs, biologics, and associated delivery devices across more than 170 countries.

Revenue
$33.0B
Employees
63,000
Founded
1923
Headquarters
Denmark

What 11 Arbolus experts think of Novo Nordisk

NPS scores in the provided insights range from 3 to 10, with the majority clustering at 8-9. High renewal intent aligns with those giving top NPS scores, particularly among Influencers at high spend levels. Most Users remain in mature implementation stages, demonstrating stickiness, while newer or pilot-stage Users report moderately positive sentiment. Key themes include established effectiveness and vendor reliability.Overall Customer Sentiment: Positive

Who reviewed Novo Nordisk

Total customers 11 11 current · 0 former
Reviews growth +4 in six months
Seniority of respondents
  • C-Suite 64% (7)
  • Director 27% (3)
  • Manager 9% (1)
Not specified Director NPS 9
Operations Ops C-Suite NPS 10 Undecided
Operations Leader C-Suite NPS 9 Will renew

Employer names and spend open once the report publishes.

Tell us when the Novo Nordisk report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

36 Net Promoter Score, from 11 scored reviews
  • Promoters 5
  • Passives 5
  • Detractors 1

Cumulative NPS by month

+2 over 6 months
  • Jan 6
  • Feb 7
  • Mar 7
  • May 8
  • Aug 8
  • Sep 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 36 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 9/10 Average score from undecided customers

For people who use Novo Nordisk

Do you use Novo Nordisk at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 11 customers of Novo Nordisk have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.